New

Asia Pacific Brain Cancer Diagnostics Market

2021

Medical Device Asia Pacific Brain Cancer Diagnosti...

Asia Pacific Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others); Cancer Type (Acoustic Neuroma, Astrocytoma, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025896 | No. of Pages: 159 | Category: Medical Device | Status: Published

Market Insights

Asia Pacific Brain Cancer Diagnostics Market to Grow at a CAGR of 17.5% to reach US$ 551.4 million by 2028 Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The brain cancer diagnostics market in Asia Pacific is expected to grow from US$ 178.6 million in 2021 to US$ 551.4 million by 2028; it is estimated to grow at a CAGR of 17.5% from 2021 to 2028.


Currently, there is insufficient evidence that they are less harmful than traditional cigarettes. Researchers at Wake Forest School of Medicine have discovered that nicotine promotes the spread of lung cancer cells to the brain, thereby forming deadly metastatic tumors. The study, published in the Journal of Experimental Medicine (JEM), suggests that nicotine replacement therapy may not be suitable for lung cancer patients trying to quit smoking. Thus, the increase in the number of cigarette smokers is bolstering the growth of the brain cancer diagnostics market.
The outbreak has severely affected the medical tourism industry in Asia pacific and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure, restrictions imposed by hospitals to the suppliers, decreasing in demand of brain cancer diagnostics devices and others. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent the disease transmission. These restrictive measures are anticipated to impact the supply chain and the availability of medical devices in these countries. It has affected disposable incomes and has also resulted in unemployment. Furthermore, business strategies such as acquisitions, mergers, and partnerships are adversely affected by the imposition of complete lockdown. Such obstructions in business activities are projected to hamper the adoption of various technologically advanced healthcare systems, including brain cancer diagnostics.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the brain cancer diagnostics market. The Asia Pacific brain cancer diagnostics market is expected to grow at a good CAGR during the forecast period.

Asia Pacific brain cancer diagnostics market

Get more information on this report :


Asia Pacific Brain Cancer Diagnostics Market Segmentation

By Diagnostic Type

  • Imaging Test
    • MRI
    • CT Scan
    • PET
  • Biopsy
  • Molecular Testing
  • Lumbar Puncture
  • Others

By Cancer Type

  • Glioblastoma Multiforme
  • Astrocytomas
  • Ependymomas
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Country

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers A
  • GE Healthcare
  • Biocept, Inc.
  • Koninklijke Philips N.V
  • Canon Medical Systems
  • Hitachi, Ltd.
  • Neusoft Medical Systems

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Brain Cancer Diagnostics Market – By End User

1.3.4 Asia Pacific Brain Cancer Diagnostics Market – By Country

2. Asia Pacific Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Brain Cancer Diagnostics Market- Asia Pacific PEST Analysis

4.3 Expert Opinion

5. Asia Pacific Brain Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Market Opportunities

5.3.1 Increasing Opportunities in Emerging Economies

5.4 Future Trends

5.4.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.5 Impact Analysis

6. Brain Cancer Diagnostics Market – Asia Pacific Analysis

6.1 Asia Pacific Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End user

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 Asia Pacific: Brain Cancer Diagnostics Market

10.1.1 Overview

10.1.2 Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.3 China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1 China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2 China: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.1.3.2.1 China: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.1.3.3 China: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.1.3.4 China: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.4 Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.1 Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2 Japan: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.1.4.2.1 Japan: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.1.4.3 Japan: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.1.4.4 Japan: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.5 India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1 India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2 India: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.1.5.2.1 India: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.1.5.3 India: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.1.5.4 India: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.6 Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1 Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2 Australia: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.1.6.2.1 Australia: Brain Cancer Diagnostics Market, By Imaging Tests, 2019–2028 (USD Million)

10.1.6.3 Australia: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.1.6.4 Australia: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.7 South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.1 South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.2 South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.1.7.2.1 South Korea: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.1.7.3 South Korea: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.1.7.4 South Korea: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

10.1.8 Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.1 Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.2 Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)

10.1.8.2.1 Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)

10.1.8.3 Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)

10.1.8.4 Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)

11. Impact Of COVID-19 Pandemic on Asia Pacific Brain Cancer Diagnostics Market

11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.1 Organic Developments

12.1.1 Overview

12.2 Inorganic Developments

12.2.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Biocept, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Koninklijke Philips N.V.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Canon Medical Systems

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Hitachi, Ltd.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Neusoft Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms


LIST OF TABLES

Table 1. China: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 2. China: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3. China: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4. China: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5. Japan: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

Table 6. Japan: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)

Table 7. Japan: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. India: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

Table 10. India: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)

Table 11. India: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12. India: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13. Australia: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Australia: Brain Cancer Diagnostics Market, By Imaging Tests – Revenue and Forecast to 2028 (USD Million)

Table 15. Australia: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

Table 16. Australia: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 18. South Korea: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 19. South Korea: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 20. South Korea: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25. Organic Developments in the Brain Cancer Diagnostics Market

Table 26. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 27. Glossary of Terms, Brain Cancer Diagnostics Market


LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. Asia Pacific Brain Cancer Diagnostics Market Overview

Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Brain Cancer Diagnostics Market - Asia Pacific PEST Analysis

Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7. Asia Pacific Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Asia Pacific: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29. China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 36. Growth Strategies Done by the Companies in the Market, (%)
  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers A
  3. GE Healthcare
  4. Biocept, Inc.
  5. Koninklijke Philips N.V
  6. Canon Medical Systems
  7. Hitachi, Ltd.
  8. Neusoft Medical Systems
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific brain cancer diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00025896
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved